[SCHEDULE 13G] Applied DNA Sciences, Inc. SEC Filing

Rhea-AI Filing Summary

Applied DNA Sciences, Inc. has a Schedule 13G reporting that three related reporting persons—Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC—may be deemed to beneficially own 143,336 shares of common stock, representing 9.99% of the common stock on a diluted basis. The filing explains those shares are issuable upon exercise of a warrant held by Intracoastal ("Intracoastal Warrant 1") and notes blocker provisions that limit exercise to avoid exceeding 9.99% (and a second warrant with a 4.99% blocker). The report lists shared voting and dispositive power over the 143,336 shares and provides addresses and citizenship of the reporting persons. The filing includes signed certifications and a joint filing agreement.

Positive

• Transparent disclosure of beneficial ownership equal to 143,336 shares (9.99%) on a diluted basis
• Warrant blocker provisions are explicitly disclosed, clarifying exercise limits that prevent ownership above 9.99% (and 4.99% for the second warrant)
• Reporting persons provided full identifying information including addresses, citizenship/organization and executed certifications

Negative

• None.

Insights

Securities Analyst

TL;DR The reporting persons disclose a near-10% diluted stake via warrants with blocker provisions; ownership is shared rather than sole.

The Schedule 13G shows the reporting persons collectively may be deemed to beneficially own 143,336 shares, equal to 9.99% on a diluted basis based on 1,291,465 reported outstanding shares plus the warrant shares. The ownership arises from a warrant (Intracoastal Warrant 1) and is subject to explicit blocker provisions that prevent exercise above 9.99% (and a second warrant limited to 4.99%). The filing reports shared voting and dispositive power and includes required certifications and signatures, indicating passive disclosure under Schedule 13G rather than an active Section 13(d) acquisition filing.

Corporate Governance Expert

TL;DR The disclosure is a routine, passive ownership filing documenting a material-but-blocked warrant position and shared control elements.

The document identifies the reporting persons and their principal business addresses and confirms U.S. citizenship/Delaware organization where applicable. It quantifies the dilutive calculation basis (1,291,465 shares outstanding as reported August 12, 2025) and explains exclusions due to blocker provisions for two warrants. The certification language confirms the holders state the position is not intended to change control. The filing form and signatures are complete and conform to Schedule 13G presentation.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Applied DNA Sciences, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

03815U607

(CUSIP Number)

07/08/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 03815U607

1

Names of Reporting Persons

Mitchell P. Kopin

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 143,336.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 143,336.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

143,336.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP No. 03815U607

1

Names of Reporting Persons

Daniel B. Asher

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 143,336.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 143,336.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

143,336.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP No. 03815U607

1

Names of Reporting Persons

Intracoastal Capital LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 143,336.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 143,336.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

143,336.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Applied DNA Sciences, Inc.
(b)	Address of issuer's principal executive offices: 50 Health Sciences Drive, Stony Brook, New York 11790
Item 2.
(a)	Name of person filing: This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons").
(b)	Address or principal business office or, if none, residence: The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 1011 Lake Street, Suite 311, Oak Park, Illinois 60301.
(c)	Citizenship: Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company.
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 03815U607
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: As of the close of business on September 5, 2025, each of the Reporting Persons may have been deemed to have beneficial ownership of 143,336 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal ("Intracoastal Warrant 1"), and all such shares of Common Stock represent beneficial ownership of approximately 9.99% of the Common Stock, based on (1) 1,291,465 shares of Common Stock outstanding as of August 12, 2025, as reported by the Issuer, plus (2) 143,336 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1. The foregoing excludes (I) 292,181 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1 because Intracoastal Warrant 1 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 1 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Common Stock and (II) 250 shares of Common Stock issuable upon exercise of a second warrant held by Intracoastal ("Intracoastal Warrant 2") because Intracoastal Warrant 2 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 2 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock. Without such blocker provisions, each of the Reporting Persons may have been deemed to have beneficial ownership of 435,767 shares of Common Stock.
(b)	Percent of class: 9.99%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 143,336
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 143,336
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Mitchell P. Kopin

Signature:	/s/ Mitchell P. Kopin
Name/Title:	Mitchell P. Kopin
Date:	09/08/2025

Daniel B. Asher

Signature:	/s/ Daniel B. Asher
Name/Title:	Daniel B. Asher
Date:	09/08/2025

Intracoastal Capital LLC

Signature:	/s/ Mitchell P. Kopin
Name/Title:	Mitchell P. Kopin, Manager
Date:	09/08/2025

Comments accompanying signature: Exhibit 1 - Joint Filing Agreement

FAQ

How many APDN shares do the reporting persons beneficially own?

They report beneficial ownership of 143,336 shares, representing 9.99% of the common stock on a diluted basis.

What is the basis for the 9.99% calculation in the Schedule 13G for APDN?

The percentage is based on 1,291,465 shares outstanding (as of August 12, 2025) plus 143,336 shares issuable upon exercise of Intracoastal Warrant 1.

Do the reporting persons have sole voting or dispositive power over the shares?

No; the filing shows 0 sole voting power and 143,336 shared voting power, and 0 sole dispositive power with 143,336 shared dispositive power.

Are there any restrictions on exercising the warrants that create these shares?

Yes; Intracoastal Warrant 1 and Intracoastal Warrant 2 contain blocker provisions that limit exercise to avoid exceeding 9.99% and 4.99% beneficial ownership thresholds, respectively.

Did the filers certify intent regarding control of the issuer?

Yes; the certifications state the securities were not acquired to change or influence control of the issuer and the filing includes signed statements dated September 8, 2025.